Last reviewed · How we verify

NCT03642821: INSTANT

Intracranial Aneurysms Treatment With the OPTIMA Coil System

Completed Last updated 18 September 2025
What this trial tests

trial testing intracranial aneurysm coiling in Intracranial Aneurysm in 300 participants. Completed in 15 February 2023.

Timeline
1 March 2019
Primary endpoint
13 October 2021
15 February 2023

Quick facts

Lead sponsorBalt Extrusion
StatusCompleted
Study typeOBSERVATIONAL
Enrollment300
Start date1 March 2019
Primary completion13 October 2021
Estimated completion15 February 2023
Sites20 locations across France, Italy, Austria, Germany, Switzerland, Spain, Latvia

Drugs / interventions tested

Conditions studied

Sponsor

Balt Extrusion

Who can join

18 and older, any sex, with Intracranial Aneurysm or Coiling Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

International, non-randomized, European , multicenter, observational study to collect data for the treatment of intracranial aneurysms with OPTIMA coils system to further document its safety and efficacy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Intracranial Aneurysm

Currently open trials in the same condition.

Other Balt Extrusion trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03642821.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing